Effect of cyclooxygenase-2 inhibition on renal function in elderly persons receiving a low-salt diet. A randomized, controlled trial

Annals of Internal Medicine

Volumn 133, Issue 1, 2000, Pages 1-9

  Swan, Suzanne K ^a   Rudy, David W ^a   Lasseter, Kenneth C ^a   Ryan, Charles F ^a   Buechel, Kristin L ^a   Lambrecht, Laurence J ^a   Pinto, Manuel B ^a   Dilzer, Stacy C ^a   Obrda, Olga ^a   Sundblad, Kimberly J ^a   Gumbs, Carol P ^a   Ebel, David L ^a   Quan, Hui ^a   Larson, Patrick J ^a   Schwartz, Jules I ^a   Musliner, Thomas A ^a   Gertz, Barry J ^a   Brater, D Craig ^a   Yao, Siu Long ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; INDOMETACIN; INULIN; IOTALAMIC ACID; PLACEBO; POTASSIUM; ROFECOXIB; SODIUM;

ADULT; AGED; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREATININE CLEARANCE; CROSSOVER PROCEDURE; DOSE CALCULATION; DOSE KIDNEY FUNCTION RELATION; DRUG EFFECT; DRUG SAFETY; ELECTROLYTE BLOOD LEVEL; ENZYME INHIBITION; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; POTASSIUM URINE LEVEL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SODIUM RESTRICTION; SODIUM URINE LEVEL;

EID: 0034604272     PISSN: 00034819     EISSN: None     Source Type: Journal    
DOI: 10.7326/0003-4819-133-1-200007040-00002     Document Type: Article

References (25)

1. Crofford LJ, Wilder RL, Ristimaki AP, Sano H, Remmers EF, Epps HR, et al. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues. Effects of interleukin-1 beta, phorbol ester, and corticosteroids. J Clin Invest. 1994;93:1095-101.
2. Hla T, Neilson K. Human cyclooxygenase-2 cDNA. Proc Natl Acad Sci U S A. 1992;89:7384-8.
3. Holtzman MJ, Turk J, Shornick LP. Identification of a pharmacologically distinct prostaglandin H synthase in cultured epithelial cells. J Biol Chem. 1992;267:21438-45.
4. Sirois J, Simmons DL, Richards JS. Hormonal regulation of messenger ribonucleic acid encoding a novel isoform of prostaglandin endoperoxide H synthase in rat preovulatory follicles. Induction in vivo and in vitro. J Biol Chem. 1992;267:11586-92.
5. Cryer B, Feldman M. Cyclooxygenase-1 and cyclooxygenase-2 selectivity of widely used nonsteroidal anti-inflammatory drugs. Am J Med. 1998;104: 413-21.
6. Meade EA, Smith WL, DeWitt DL. Differential inhibition of prostaglandin endoperoxide synthase (cyclooxygenase) isozymes by aspirin and other non-steroidal anti-inflammatory drugs. J Biol Chem. 1993;268: 6610-4.
7. Ehrich EW, Dallob A, De Lepeleire I, Van Hecken A, Riendeau D, Yuan W, et al. Characterization of rofecoxib as a cyclooxygenase-2 isoform inhibitor and demonstration of analgesia in the dental pain model. Clin Pharmacol Ther. 1999;65:336-47.
8. Komhoff M, Crone HJ, Klein T, Seyberth HW, Nusing R. Localization of cyclooxygenase-1 and -2 in adult and fetal human kidney: implication for renal function. Am J Physiol. 1997:272(4 Pt 2):F460-8.
9. Harris RC, McKanna JA, Akai Y, Jacobson HR, Dubois RN, Breyer MD. Cyclooxygenase-2 is associated with the macula dcnsa of rat kidney and increases with salt restriction. J Clin Invest. 1994;94:2504-10.
10. Rossat J, Maillard M, Nussberger J, Brunner HR, Burnier M. Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects. Clin Pharmacol Ther. 1999;66:76-84.
11. Kramer HJ, Stinnesbeck B, Klautke G, Kipnowsi J, Klingmueller D, Glaenzer K, et al. Interaction of renal prostaglandins with the renin-angiotensin and renal adrenergic nervous systems in healthy subjects during dietary changes in sodium intake. Clin Sci. 1985;68:387-93.
12. Muther RS, Potter DM, Bennett WM. Aspirin-induced depression of glomerular filtration rate in normal humans: role of sodium balance. Ann Intern Med. 1981;94:317-21.
13. Fjeldbo W, Stamey TA. Adapted method for determination of inulin in serum and urine with an AutoAnalyzer. J Lab Clin Med. 1968;72:353-8.
14. 125I labeled sodium iothalamate in man. Invest Urol (Berl). 1965;2:432.
15. Sigman EM, Elwood CM, Knox F. The measurement of glomerular filtration rate in man with sodium iothalamate 1.31-I (Conray). J Nucl Med. 1966;7:60-8.
16. Brater DC, Anderson SA, Brown-Cartwright D, Toto RD, Chen A, Jacob GB. Effect of etodolac in patients with moderate renal impairment compared with normal subjects. Clin Pharmacol Ther. 1985;38:674-9.
17. Murray MD, Black PK, Kuzmik DD, Haag KM, Manatunga AK, Mullin MA, et al. Acute and chronic effects of nonsteroidal antiinflammatory drugs on glomerular filtration rate in elderly patients. Am J Med Sci. 1995;310:188-97.
18. Toto RD, Anderson SA, Brown-Cartwright D, Kokko JP, Brater DC. Effects of acute and chronic dosing of NSAIDs in patients with renal insufficiency. Kidney Int. 1986;30:760-8.
19. Murray MD, Greene PK, Brater DC, Manatunga AK, Hall SD. Effects of flurbiprofen on renal function in patients with moderate renal insufficiency. Br J Clin Pharmacol. 1992;33:385-93.
20. Murray MD, Brater DC. Adverse effects of nonsteroidal anti-inflammatory drugs on renal function [Editorial]. Ann Intern Med. 1990;112:559-60.
21. Donker AJ, Arisz L, Brentjens JR, van der Hem GK, Hollemans HJ. The effect of indomethacin on kidney function and plasma renin activity in man. Nephron. 1976;17:288-96.
22. Brater DC. Effect of indomethacin on salt and water homeostasis. Clin Pharmacol Ther. 1979;25:322-30.
23. Dusing R, Kipnowski J, Kramer HJ. Prostaglandins and renal NaCI excretion in healthy human subjects: effects of prostaglandin synthesis inhibition with indomethacin. Klin Wochenschr. 1982;60:1229-33.
24. Catella-Lawson F, McAdam B, Morrison BW, Kapoor S, Kujubu D, Antes L, et al. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids. J Pharmacol Exp Ther. 1999;289:735-41.
25. Murray MD, Lazaridis EN, Brizendine E, Haag K, Becker P, Brater DC. The effect of nonsteroidal antiinflammatory drugs on electrolyte homeostasis and blood pressure in young and elderly persons with and without renal insufficiency. Am J Med Sci. 1997;314:80-8.